Thalamanol

ANAQUEST DIV OF BOC INC -- ENLON EDROPHONIUM CHLORIDE, USP -- 6505-01-302-2670
=====================  Product Identification  =====================

Product ID:ENLON EDROPHONIUM CHLORIDE, USP
MSDS Date:03/01/1992
FSC:6505
NIIN:01-302-2670
MSDS Number: BMZNJ
=== Responsible Party ===
Company Name:ANAQUEST DIV OF BOC INC
Address:2005 W BELTLINE HWY
City:MADISON
State:WI
ZIP:53713-2337
Country:US
Info Phone Num:908-647-9200
Emergency Phone Num:800-535-5053
Preparer's Name:DEBORAH SHEWITZ
CAGE:65171
=== Contractor Identification ===
Company Name:ANAQUEST DIV OF BOC INC
Address:2005 W BELTLINE HWY
Box:City:MADISON
State:WI
ZIP:53713-2337
Country:US
Phone:608-273-0019
CAGE:65171

=============  Composition/Information on Ingredients  =============

Ingred Name:EDROPHONIUM CHLORIDE
CAS:116-38-1
Other REC Limits:NONE SPECIFIED

Ingred Name:SODIUM CITRATE
CAS:6132-04-3
Other REC Limits:NONE SPECIFIED

=====================  Hazards Identification  =====================

Routes of Entry: Inhalation:NO	Skin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:ACUTE: MAY CAUSE IRRITATION OF SKIN
    AND EYES ON CONTACT. MAY CAUSE CENTRAL NERVOUS SYSTEM STIMULATION
    FOLLOWED BY DEPRESSION IF INGESTED OR ACCIDENTLY INJECTED. CHRONIC:
    NONE SPECIFIED BY MANUFACTURER .
Explanation of Carcinogenicity:NO INGREDIENT OF A CONCENTRATION OF 0.1
    % OR GREATER IS LISTED AS A CARCINOGEN OR SUSPECTED CARCINOGEN.
Effects of Overexposure:EYES: TEARING, BURNING SENSATION, REDNESS.
    SKIN: REDNESS, RASH, ITCHING. INJECTED/INGESTED: AGITATION,
    HYPERACTIVITY; THEN HEADACHE, STUPOR, DIZZINESS.
Medical Cond Aggravated by Exposure:SENSITIVE PERSONS MAY EXPERIENCE
    PROBLEMS WITH CHOLINERGIC NERVES.

=======================  First Aid Measures  =======================

First Aid:INHALATION: REMOVE TO FRESH AIR. RESUSCITATE IF NEEDED. EYES:
    FLUSH WITH PLENTY OF WATER FOR 15 MINUTES. SEE DOCTOR. SKIN: REMOVE
    CONTAMINATED CLOTHES AND RINSE WITH WATER FOR 5 MINUTES.
    INGESTED/INJE CTED: TREAT SYMPTOMATICALLY; IF SEVERE REACTION; GIVE
    ATROPINE SULFATE.

=====================  Fire Fighting Measures  =====================

Flash Point:NONFLAMMABLE
Extinguishing Media:MEDIA APPROPRIATE FOR SURROUNDING FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
    FULL PROTECTIVE GEAR.
Unusual Fire/Explosion Hazard:FIRE MAY PRODUCE IRRITATING OR HARMFUL
    GASES.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WIPE UP WITH RAGS OR SIMILAR MATERIALS. PLACE
    IN CONTAINERS FOR LATER DISPOSAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

======================	Handling and Storage  ======================

Handling and Storage Precautions:STORE IN A COOL, DRY PLACE. KEEP
    CONTAINERS TIGHTLY CLOSED.
Other Precautions:NONE SPECIFIED BY MANUFACTURER.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:NONE NORMALLY REQUIRED.
Ventilation:USE ADEQUATE MECHANICAL VENTILATION.
Protective Gloves:RUBBER
Eye Protection:SAFETY GLASSES WHERE SPLASHING OCCURS
Other Protective Equipment:NONE SPECIFIED BY MANUFACTURER.
Work Hygienic Practices:WASH HANDS AFTER USE AND BEFORE EATING,
    DRINKING, OR SMOKING. LAUNDER CONTAMINATED CLOTHES BEFORE REUSE.
Supplemental Safety and Health

==================  Physical/Chemical Properties  ==================

HCC:N1
Boiling Pt:B.P. Text:>212F,>100C
Vapor Pres:23.8
Vapor Density:<1 (AIR=1)
Spec Gravity:1
pH:5.4
Evaporation Rate & Reference:<1 (DIETHYL ETHER=1)
Solubility in Water:APPRECIABLE
Appearance and Odor:CLEAR, COLORLESS, ODORLESS LIQUID
Percent Volatiles by Volume:96

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
STRONG ALKALIS
Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER.
Hazardous Decomposition Products:NONE SPECIFIED BY MANUFACTURER.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND
    FEDERAL REGULATIONS. MANUFACTURER STATES: FOLLOW PROCEDURES FOR
    DIPOSAL FOR ACTIVE DRUGS.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.